Friday, July 10, 2026

Drug profile · INN

insulin aspart-xjhz

insulin aspart-xjhz (KIRSTY) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — insulin aspart-xjhz
US status
approved
Class
Route
SOLUTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

insulin aspart-xjhz (KIRSTY) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.

Key facts

INN insulin aspart-xjhz
Brand KIRSTY
Route SOLUTION
Formulation INJECTION

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is insulin aspart-xjhz?

insulin aspart-xjhz (KIRSTY) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.

What is the brand name for insulin aspart-xjhz?

KIRSTY is a marketed brand name for insulin aspart-xjhz. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of insulin aspart-xjhz?

insulin aspart-xjhz has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.